Volumetric brain reductions in adult patients with phenylketonuria and their relationship with blood phenylalanine levels
-
Published:2024-06-21
Issue:1
Volume:16
Page:
-
ISSN:1866-1955
-
Container-title:Journal of Neurodevelopmental Disorders
-
language:en
-
Short-container-title:J Neurodevelop Disord
Author:
Pardo JèssicaORCID, Capdevila-Lacasa ClaraORCID, Segura BàrbaraORCID, Pané AdrianaORCID, Montserrat Cristina, de Talló Forga-Visa Maria, Moreno Pedro J.ORCID, Garrabou GlòriaORCID, Grau-Junyent Josep M.ORCID, Junqué CarmeORCID, , Argudo-Ramírez Ana, Barrau-Martínez Blanca, Cantó Judith, Campistol Jaume, Cardellach Francesc, Casals-Pascual Climent, Chiva-Blanch Gemma, García-Arenas Dolores, García-García Francesc Josep, García-Villoria Judit, González de Aledo-Castillo José Manuel, González-Rodríguez Arnau, Guitart-Mampel Mariona, Isern Paula, Jiménez Amanda, Laudo Berta, Llorach Rafael, Andújar-Sánchez Félix, López-Galera Rosa, Meavilla Silvia Mª, Milisenda José Cesar, Morales Blai, Moreno-Lozano Pedro Juan, Moreno Julián, Nos Mònica, Ormazabal Aida, Ortega Ferrer Montserrat, Ortega Emilio, Padrosa Joan, Paredes Abraham José, Rubio Elisa, Tobías Ester, Torremade Josep, Urpi-Sarda Mireia, Valls Laura, Ventura Roser, Vergara-Gómez Andrea, Viaplana Judith, Viñals Clara
Abstract
Abstract
Background
Continued dietary treatment since early diagnosis through newborn screening programs usually prevents brain-related complications in phenylketonuria (PKU). However, subtle neurocognitive and brain alterations may be observed in some adult patients despite early treatment. Nevertheless, neuropsychological and neuroimaging studies in the field remain scarce.
Objectives
This work aimed to determine possible neuropsychological and structural brain alterations in treated adult patients with PKU.
Methods
Thirty-five patients with PKU and 22 healthy controls (HC) underwent neuropsychological assessment and T1-weighted magnetic resonance imaging on a 3 T scanner. FreeSurfer (v.7.1) was used to obtain volumetric measures and SPSS (v27.0.1.0) was used to analyze sociodemographic, neuropsychological, volumetric, and clinical data (p < 0.05).
Results
Adult patients with PKU showed significantly lower performance than HC in Full Scale IQ (t = 2.67; p = .010) from the WAIS-IV. The PKU group also showed significantly lower volumes than HC in the pallidum (U = 224.000; p = .008), hippocampus (U = 243.000; p = .020), amygdala (U = 200.000; p = .002), and brainstem (t = 3.17; p = .006) as well as in total cerebral white matter volume (U = 175.000; p = .001). Blood phenylalanine (Phe) levels in PKU patients were negatively correlated with the pallidum (r = -0.417; p = .013) and brainstem (r = -0.455, p = .006) volumes.
Conclusions
Adult patients with early-treated PKU showed significantly lower global intelligence than HC. Moreover, these patients showed reduced global white matter volume as well as reductions in the volume of several subcortical grey matter structures, which might be related to the existence of underlying neurodevelopmental alterations. Higher blood Phe levels were also negatively correlated with pallidum and brainstem, suggesting a higher vulnerability of these structures to Phe toxicity.
Funder
Ministry of Science and Innovation, Spain Fundació la Marató de TV3
Publisher
Springer Science and Business Media LLC
Reference41 articles.
1. Van Spronsen FJ, van Wegberg AM, Ahring K, Bélanger-Quintana A, et al. Key European guidelines for the diagnosis and management of patients with phenylketonuria. Rev Lancet Diabetes Endocrinol. 2017;5:743–56. 2. de Groot MJ, Hoeksma M, Blau N, Reijngoud DJ, van Spronsen FJ. Pathogenesis of cognitive dysfunction in phenylketonuria: review of hypotheses. Mol Genet Metab. 2010;99(SUPPL.):S86–9. 3. Anderson PJ, Leuzzi V. White matter pathology in phenylketonuria☆. Mol Genet Metab. 2010;99:S3–9. 4. Ferreira BK, Rodrigues MT, Streck EL, Ferreira GC, Schuck PF. White matter disturbances in phenylketonuria: possible underlying mechanisms. J Neurosci Res. 2021;99:349–60 John Wiley and Sons Inc. 5. Moat SJ, Schulenburg-Brand D, Lemonde H, Bonham JR, Weykamp CW, Mei JV, et al. Performance of laboratory tests used to measure blood phenylalanine for the monitoring of patients with phenylketonuria. J Inherit Metab Dis. 2020;43(2):179–88.
|
|